10-133281368-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006659.4(TUBGCP2):c.2478C>A(p.Asp826Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000123 in 1,613,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006659.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TUBGCP2 | NM_006659.4 | c.2478C>A | p.Asp826Glu | missense_variant | 17/18 | ENST00000252936.8 | NP_006650.1 | |
TUBGCP2 | NM_001256617.2 | c.2562C>A | p.Asp854Glu | missense_variant | 18/19 | NP_001243546.1 | ||
TUBGCP2 | NM_001256618.2 | c.2088C>A | p.Asp696Glu | missense_variant | 16/17 | NP_001243547.1 | ||
TUBGCP2 | NR_046330.2 | n.3198C>A | non_coding_transcript_exon_variant | 17/18 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152198Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000199 AC: 50AN: 251142Hom.: 0 AF XY: 0.000191 AC XY: 26AN XY: 135836
GnomAD4 exome AF: 0.000121 AC: 177AN: 1461588Hom.: 0 Cov.: 31 AF XY: 0.000118 AC XY: 86AN XY: 727098
GnomAD4 genome AF: 0.000145 AC: 22AN: 152198Hom.: 0 Cov.: 33 AF XY: 0.000135 AC XY: 10AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2022 | The c.2478C>A (p.D826E) alteration is located in exon 17 (coding exon 16) of the TUBGCP2 gene. This alteration results from a C to A substitution at nucleotide position 2478, causing the aspartic acid (D) at amino acid position 826 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at